CytoSorbents (CTSO) announced the appointment of Alexander D’Amico as Chief Financial Officer, CFO, to begin employment on August 7, 2023. D’Amico brings over 20 years of broad finance, SEC reporting, merger and acquisition, fundraising, and accounting experience to CytoSorbents. Most recently, D’Amico was the Chief Financial Officer of Trulieve Cannabis Corporation (TCNNF)
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CTSO:
- CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
- CytoSorbents, Humedics announce theranostic collaboration
- CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
- CytoSorbents completes enrollment of STAR-T trial
- CytoSorbents announces independent DSMB recommends completion of STAR-T trial
